Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 9, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

April 30, 2027

Conditions
Epiretinal MembraneMacular OedemaMacular DiseasesRetinal Diseases
Interventions
DEVICE

Subtreshold micropulse laser therapy

Laser-treated group will receive additional subthreshold micropulse laser therapy (SMLT) 1 month after pars plana vitrectomy (PPV), using a 577 nm solid-state yellow diode laser applied to the macular area (thirty 5 × 5 spot sizes of 160 µm, zero-spot spacing, including the fovea; fixed power 250 mW; exposure time 200 ms; micropulse mode, 5% duty cycle). Control group (nonlaser group) will not receive additional laser treatment.

PROCEDURE

Pars plana vitrectomy

Both groups will undergo pars plana vitrectomy (PPV) with epiretinal membrane (ERM) and internal limiting membrane (ILM) peeling prior to allocation to study arms.

Trial Locations (1)

Unknown

First Department of Ophthalmology, Pomeranian Medical University, Szczecin

All Listed Sponsors
lead

Pomeranian Medical University Szczecin

OTHER